Literature DB >> 29171797

Health-related quality of life outcomes in complex adult spinal deformity surgery.

Max S Riley1, Keith H Bridwell1, Lawrence G Lenke2, Jonathan Dalton1, Michael P Kelly1.   

Abstract

OBJECTIVE Significant health-related quality of life (HRQOL) benefits have been observed for patients undergoing primary and revision adult spinal deformity (ASD) surgery. The purpose of this study was to report changes in HRQOL measures in a consecutive series of patients undergoing complex spinal reconstructive surgery, using Scoli-RISK-1 (SR-1) inclusion criteria. METHODS This was a single-center, retrospective cohort study. The SR-1 inclusion criteria were used to define patients with complex ASD treated between June 1, 2009, and June 1, 2011. Standard preoperative and perioperative data were collected, including the Scoliosis Research Society (SRS)-22r instrument. The HRQOL changes were evaluated at a minimum 2-year follow-up. Standardized forms were used to collect surgery-related complications data for all patients. Complications were defined as minor, transient major, or permanent major. Patients who achieved a minimum 2-year follow-up were included in the analysis. RESULTS Eighty-four patients meeting SR-1 criteria were identified. Baseline demographic and surgical data were available for 74/84 (88%) patients. Forty-seven of 74 (64%) patients met the additional HRQOL criteria with a minimum 2-year follow-up (mean follow-up 3.4 years, range 2-6.5 years). Twenty-one percent of patients underwent posterior fusion only, 40% of patients had a posterior column osteotomy, and 38% had a 3-column osteotomy. Seventy-five percent of patients underwent a revision procedure. Significant improvements were observed in all SRS-22r domains: Pain: +0.8 (p < 0.001); Self-Image: +1.4 (p < 0.001); Function: +0.46 (p < 0.001); Satisfaction: +1.6 (p < 0.001); and Mental Health: +0.28 (p = 0.04). With the exception of Mental Health, more than 50% of patients achieved a minimum clinically important difference (MCID) in SRS-22r domain scores (Mental Health: 20/47, 42.6%). A total of 65 complications occurred in 31 patients. This includes 29.8% (14/47) of patients who suffered a major complication and 17% (8/47) who suffered a postoperative neurological deficit, most commonly at the root level (10.6%, 5/47). Of the 8 patients who suffered a neurological deficit, 1 (13%) was able to achieve MCID in the SRS Function domain. CONCLUSIONS The majority of patients experienced clinically relevant improvement in SRS-22r HRQOL scores after complex ASD surgery. The greatest improvements were seen in the SRS Pain and SRS Self-Image domains. Although 30% of patients suffered a major or permanent complication, benefits from surgery were still attained. Patients sustaining a neurological deficit or major complication were unlikely to achieve HRQOL improvements meeting or exceeding MCID for the SRS Function domain.

Entities:  

Keywords:  3-CO = 3-column osteotomy; ASD = adult spinal deformity; HRQOL = health-related quality of life; IOM = intraoperative neurophysiological monitoring; MCID = minimum clinically important difference; SR-1 = Scoli-RISK-1; SRS = Scoliosis Research Society; Scoli-RISK-1; adult spinal deformity; complex; osteotomy; outcomes; scoliosis; subtraction

Mesh:

Year:  2017        PMID: 29171797     DOI: 10.3171/2017.6.SPINE17357

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  7 in total

1.  The "Kickstand Rod" technique for correction of coronal imbalance in patients with adult spinal deformity: theory and technical considerations.

Authors:  Melvin C Makhni; Meghan Cerpa; James D Lin; Paul J Park; Lawrence G Lenke
Journal:  J Spine Surg       Date:  2018-12

2.  External Validation of the European Spine Study Group-International Spine Study Group Calculator Utilizing a Single Institutional Experience for Adult Spinal Deformity Corrective Surgery.

Authors:  Peter G Passias; Sara Naessig; Ashok Para; Katherine Pierce; Waleed Ahmad; Bassel G Diebo; Renaud Lafage; Virginie Lafage; Justin S Smith; Burhan Janjua
Journal:  Int J Spine Surg       Date:  2022-07-31

3.  Return to work after adult spinal deformity surgery.

Authors:  Brian J Neuman; Kevin Y Wang; Andrew B Harris; Micheal Raad; Richard A Hostin; Themisctocles S Protopsaltis; Christopher P Ames; Peter G Passias; Munish C Gupta; Eric O Klineberg; Robert Hart; Shay Bess; Khaled M Kebaish
Journal:  Spine Deform       Date:  2022-10-11

4.  External validation of the adult spinal deformity (ASD) frailty index (ASD-FI).

Authors:  Emily K Miller; Alba Vila-Casademunt; Brian J Neuman; Daniel M Sciubba; Khaled M Kebaish; Justin S Smith; Ahmet Alanay; Emre R Acaroglu; Frank Kleinstück; Ibrahim Obeid; Francisco Javier Sánchez Pérez-Grueso; Leah Y Carreon; Frank J Schwab; Shay Bess; Justin K Scheer; Virginie Lafage; Christopher I Shaffrey; Ferran Pellisé; Christopher P Ames
Journal:  Eur Spine J       Date:  2018-03-30       Impact factor: 3.134

5.  Correction of a severe coronal malalignment in adult spinal deformity using the "kickstand rod" technique as primary surgery.

Authors:  Luca Proietti; Andrea Perna; Calogero Velluto; Amarildo Smakaj; Maria Beatrice Bocchi; Caterina Fumo; Luca Fresta; Francesco Ciro Tamburrelli
Journal:  J Orthop       Date:  2021-05-20

6.  Does Local Administration of Liposomal Bupivacaine Reduce Pain and Narcotic Consumption in Adult Spinal Deformity Surgery?

Authors:  Andrew S Chung; Dennis Crandall; Jan Revella; Biodun Adeniyi; Yu Hui H Chang; Michael S Chang
Journal:  Global Spine J       Date:  2020-06-22

7.  Are Higher Global Alignment and Proportion Scores Associated With Increased Risks of Mechanical Complications After Adult Spinal Deformity Surgery? An External Validation.

Authors:  Kenny Yat Hong Kwan; Lawrence G Lenke; Christopher I Shaffrey; Leah Y Carreon; Benny T Dahl; Michael G Fehlings; Christopher P Ames; Oheneba Boachie-Adjei; Mark B Dekutoski; Khaled M Kebaish; Stephen J Lewis; Yukihiro Matsuyama; Hossein Mehdian; Yong Qiu; Frank J Schwab; Kenneth Man Chee Cheung
Journal:  Clin Orthop Relat Res       Date:  2021-02-01       Impact factor: 4.755

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.